AZGP1 and metabolic dysfunction-associated steatotic liver disease: Since GGT may be a surrogate marker of NAFLD and dynamic changes in serum, GGT levels have been associated with an improvement in liver histology in individuals with NAFLD [27,28], and these results might postulate basal SAT/VAT ZAG gene expression levels as a useful marker to predict NAFLD response to BS.